VON WILLEBRAND DISEASE (VWD)
Clinical trials for VON WILLEBRAND DISEASE (VWD) explained in plain language.
Never miss a new study
Get alerted when new VON WILLEBRAND DISEASE (VWD) trials appear
Sign up with your email to follow new studies for VON WILLEBRAND DISEASE (VWD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New treatment cuts bleeding episodes in severe blood disorder
Disease control CompletedThis study tested a medication called rVWF (vonicog alfa) in 38 children and adults with severe von Willebrand disease, a bleeding disorder. The goal was to see how well it prevents spontaneous bleeding over 12 months. Participants received rVWF for up to 3 years, and researchers…
Matched conditions: VON WILLEBRAND DISEASE (VWD)
Phase: PHASE3 • Sponsor: Baxalta now part of Shire • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
UK study checks Real-World use of clotting drug for bleeding disorder
Knowledge-focused CompletedThis study looked back at medical records of 34 adults in the UK with von Willebrand disease (a common inherited bleeding disorder) who received a medicine called vonicog alfa (rVWF). The goal was to see how well it controlled bleeding episodes and helped during surgeries in real…
Matched conditions: VON WILLEBRAND DISEASE (VWD)
Sponsor: Takeda • Aim: Knowledge-focused
Last updated May 19, 2026 11:49 UTC